VanEck Pharmaceutical ETF
ETFYour view on PPH
VanEck Pharmaceutical ETF
ETFVanEckSentiment
AUM (USD)
$966.15M
Expense Ratio
0.36%
Holdings
26
Sentiment
Overview for VanEck Pharmaceutical ETF
- Fund Type
- ETF
- Fund Issuer
- VanEck
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- December 20, 2011
- Domicile
- US
- Fund Type
- ETF
- Fund Issuer
- VanEck
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- December 20, 2011
- Domicile
- US
- Fund Type
- ETF
- Fund Issuer
- VanEck
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- December 20, 2011
- Domicile
- US
About this fund
VanEck Pharmaceutical ETF (PPH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceutical…
PPH Stock Price
Key Facts
EquityExpense Ratio
0.36%
AUM
$966.15M
Fund Details
Expense Ratio
0.36%
Assets Under Management
$966.15M
NAV
$111.20 USD
Holdings
26
Average Volume
236.4K
Inception Date
December 20, 2011
Asset Class
Equity
Fund Issuer
VanEck
Domicile
US
ISIN
US92189F6925
CUSIP
92189F692
NAV Currency
USD
Expense Ratio
0.36%
Assets Under Management
$966.15M
NAV
$111.20 USD
Holdings
26
Average Volume
236.4K
Inception Date
December 20, 2011
Asset Class
Equity
Fund Issuer
VanEck
Domicile
US
ISIN
US92189F6925
CUSIP
92189F692
NAV Currency
USD
Latest headlines and company announcements for this company. Press releases and market coverage, newest first.
News
this company valued side by side against its closest peers. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.